ИНГАЛЯЦИОННАЯ АНЕСТЕЗИЯ В СРАВНЕНИИ С НЕИНГАЛЯЦИОННОЙ АНЕСТЕЗИЕЙ ПРИ НЕКАРДИОХИРУРГИЧЕСКИХ ОПЕРАЦИЯХ: СРАВНИТЕЛЬНЫЙ ОБЗОР КЛИНИЧЕСКИХ РЕЗУЛЬТАТОВ

М.А. Зеленецкая, К.А. Балыкина · Military and tactical medicine Emergency medicine · 2026

Выбор анестезиологической техники при некардиохирургических операциях остаётся предметом активной дискуссии. Ингаляционные анестетики, являющиеся традиционной основой общей анестезии, обладают надёжной фармакокинетикой, простотой администрирования и кардиопульмональными преимуществами. Неингаляционная анестезия с использованием пропофола и ремифентанила, поддерживаемая системами целевой инфузии и мониторами глубины анестезии, зарекомендовала себя как широко применяемая альтернатива. Целью обзора является систематизация современных данных о клинических исходах при использовании ингаляционной и неингаляционной анестезии у пациентов, переносящих некардиохирургические вмешательства. Показано, что ингаляционные анестетики демонстрируют преимущества в кардиопротекции и управлении дыханием, тогда как неингаляционная анестезия ассоциирована со снижением частоты послеоперационной тошноты и рвоты, а также потенциальными преимуществами в онкологической хирургии. Ни одна из техник не продемонстрировала последовательного превосходства во всех клинических контекстах. Выбор метода анестезии должен быть персонализирован на основе хирургического риска, сопутствующих заболеваний пациента, опыта врача The choice of anesthetic technique in noncardiac surgery remains a subject of active debate. Inhalational anesthetics, which are the traditional cornerstone of general anesthesia, offer reliable pharmacokinetics, ease of administration, and cardiopulmonary benefits. Total intravenous anesthesia (TIVA) using propofol and remifentanil, supported by target-controlled infusion systems and depth-of-anesthesia monitors, has become a widely adopted alternative. The purpose of this review is to systematize current evidence on clinical outcomes associated with inhalational and total intravenous anesthesia in patients undergoing noncardiac surgery. An analysis of 52 studies, including randomized controlled trials, meta-analyses, and observational studies, was conducted. Inhalational anesthetics demonstrated advantages in cardioprotection and airway management, whereas TIVA was associated with improved recovery profiles, reduced incidence of postoperative nausea and vomiting, and potential benefits in oncological surgery. Neither technique demonstrated consistent superiority across all clinical contexts. The choice of anesthetic technique should be personalized based on surgical risk, patient comorbidities, institutional capabilities, and clinician expertise The choice of anesthetic technique in noncardiac surgery remains a subject of active debate. Inhalational anesthetics, which are the traditional cornerstone of general anesthesia, offer reliable pharmacokinetics, ease of administration, and cardiopulmonary benefits. Total intravenous anesthesia (TIVA) using propofol and remifentanil, supported by target-controlled infusion systems and depth-of-anesthesia monitors, has become a widely adopted alternative. The purpose of this review is to systematize current evidence on clinical outcomes associated with inhalational and total intravenous anesthesia in patients undergoing noncardiac surgery. An analysis of 52 studies, including randomized controlled trials, meta-analyses, and observational studies, was conducted. Inhalational anesthetics demonstrated advantages in cardioprotection and airway management, whereas TIVA was associated with improved recovery profiles, reduced incidence of postoperative nausea and vomiting, and potential benefits in oncological surgery. Neither technique demonstrated consistent superiority across all clinical contexts. The choice of anesthetic technique should be personalized based on surgical risk, patient comorbidities, institutional capabilities, and clinician expertise.

Cited by 0 works. doi:10.55359/2782-3296.2026.57.99.002

Authors

References